IL-6 and APPs: anti-inflammatory and immunosuppressive mediators
- 1 September 1997
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 18 (9) , 428-432
- https://doi.org/10.1016/s0167-5699(97)01103-1
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- THE ROLE OF IL-4 AND IL-6 IN IL-1-DEPENDENT CARTILAGE MATRIX DEGRADATIONRheumatology, 1995
- The Role of Interleukin-6 in Mucosal IgA Antibody Responses in VivoScience, 1994
- Impaired immune and acute-phase responses in interleukin-6-deficient miceNature, 1994
- The acute phase responseImmunology Today, 1994
- Suppression of cytokine production by supernatants from CD8+ lymphocytes activated by mycobacterial fractions: The role of interleukins 4 and 6Biotherapy, 1993
- Long-Term Consequences of Interleukin-6 Overexpression in Transgenic MiceDNA and Cell Biology, 1992
- Inhibition of neutrophil superoxide production by human plasma α1‐antitrypsinFEBS Letters, 1992
- Acute Phase Protein, Serum Amyloid A, Inhibits IL‐1‐ and TNF‐Induced Fever and Hypothalamic PGE2 in MiceScandinavian Journal of Immunology, 1991
- Interleukin 6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblatsBiochemical and Biophysical Research Communications, 1990
- α2-macroglobulin ‘fast’ forms inhibit superoxide production by activated macrophagesBiochimica et Biophysica Acta (BBA) - General Subjects, 1983